After Pasteur: History of New Rabies Vaccines



One of the major problems presented by the Pasteur rabies vaccine and its numerous varieties was the presence of animal nervous tissue in the final product and the potential allergic responses to that tissue, leading to encephalitis in humans and animals. As the vaccine was also occasionally applied indiscriminately to subjects not exposed to rabies, the price of vaccination was indeed high.


Chick Embryo Rabies Virus Passage Level Rabies Vaccine Human Diploid Cell Strain 


  1. 1.
    Koporowski H, Cox HR. Studies on chick embryo adapted rabies virus. I. Culture characteristics and pathogenicity J Immunol 1948;60:533–54Google Scholar
  2. 2.
    Koprowski H, Black J. Studies on chick embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purposes J Immunol 1950;64:185–96PubMedGoogle Scholar
  3. 3.
    Koprowski H, Black J, Nelseen DJ. Studies on chick embryo adapted rabies virus. VU. Further changes in pathogenic properties following prolonged cultivation in the developing chick embryo J Immunol 1954;72:94–106PubMedGoogle Scholar
  4. 4.
    Ruegsegger JM, Black J, Sharpless GR. Primary antirabies immunization of man with HEP Flury virus vaccine Am J Public Health 1961;51:706–16CrossRefGoogle Scholar
  5. 5.
    Wiktor TJ, Koprowski H. Successful immunization of primates with rabies vaccine prepared in human diploid cell strain WI-38 Proc Soc Exp Biol Med 1965;118:1069–73PubMedGoogle Scholar
  6. 6.
    Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:595CrossRefGoogle Scholar
  7. 7.
    Wiktor TJ, Fernandez MV, Koprowski H. Potential use of human diploid cell strains for rabies vaccine. In: Proc Symp on Characterization and Uses of Human Diploid Cell Strains. Yugoslavia: Opatija, 1963Google Scholar
  8. 8.
    Wiktor TJ, Fernandez MV, Koprowski H. Cultivation of rabies virus in human diploid cell strain WI-38. J ImmunoI 1964;93:353–66Google Scholar
  9. 9.
    Koprowski H. In vitro production of antirabies virus vaccine. Int Symp on Rabies, Talloires 1965; Symp Series Immunobiol Standard 1966;1:357–66Google Scholar
  10. 10.
    Wiktor TJ, Sokol F, Kuwert E, Koprowski H. Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin. Proc Soc Exp Biol Med 1969;131:799–805PubMedGoogle Scholar
  11. 11.
    Wiktor TJ, Plotkin SA, Grella DW. Human cell culture rabies vaccine. JAMA 1973;224:1170–1Google Scholar
  12. 12.
    Plotkin SA, Wiktor TJ, Koprowski H, Rosanoff EI, Tint H. Immunization schedule for the new human diploid cell vaccine against rabies. Am J EpidemioI 1976;103:75–80Google Scholar
  13. 13.
    Plotkin SA, Wiktor TJ. Rabies vaccination. Annu Rev Med 1978;29:583–91PubMedCrossRefGoogle Scholar
  14. 14.
    Aoki FY, Tyrrell DAH, Hill LE. Immunogenicity and acceptability of a human diploid cell culture rabies vaccine in volunteers. Lancet 1975;1:660–2PubMedCrossRefGoogle Scholar
  15. 15.
    Kuwert EK, Marcus I, Werner J, Scheiermann N, Thraenhart O. Some experiences with human diploid cell strain (HDCS) rabies vaccine in pre-and post-exposure vaccinated humans. Dev Biol Stand 1978;40:79–88PubMedGoogle Scholar
  16. 16.
    Cox JH, Kleitmann W, Schneider LG. Human rabies immunoprophylaxis using HDC (MRC-5) vaccine. Dev Biol Stand 1978;40:105–8PubMedGoogle Scholar
  17. 17.
    Ajjan N, Soulebot JP, Triau R, Biron G. Intradermal immunization with rabies vaccine: inactivated Wistar strain cultivated in human diploid cells. JAMA 1980;244:2528–31PubMedCrossRefGoogle Scholar
  18. 18.
    Immunization Practices Advisory Committee (ACIP). Rabies prevention-United States, 1991. MMWR 1991;40(RR-3):1–19Google Scholar
  19. 19.
    Montagnon BJ. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line. Dev Biol Stand 1989;70:27–47PubMedGoogle Scholar
  20. 20.
    Wiktor TJ, MacFarlan RI, Reagan KJ et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 1984;81:7194–8PubMedCrossRefGoogle Scholar
  21. 21.
    Rupprecht CE, Wiktor TJ, Johnston DH et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc Natl Acad Sci USA 1986;83:7947–50PubMedCrossRefGoogle Scholar
  22. 22.
    McGarvey P, Hammond J, Dienelt MM et al. Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology 1995;13:1484–7PubMedCrossRefGoogle Scholar
  23. 23.
    Yuslbov V, Hooper DC, Spitsin SV et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 2002;20:3155–64Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Jefferson Cancer InstituteThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations